...
首页> 外文期刊>Abdominal radiology. >Hepatic mosaic enhancement pattern correlates with increased inflammatory activity and adverse therapeutic outcomes in patients with Crohn's disease
【24h】

Hepatic mosaic enhancement pattern correlates with increased inflammatory activity and adverse therapeutic outcomes in patients with Crohn's disease

机译:肝马赛克增强模式与克罗恩病患者的炎症活性和不良治疗结果相关联

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose This study aimed to evaluate the role of hepatic mosaic enhancement pattern (HMEP) on computed tomography images in the disease activity and therapeutic outcome of Crohn's Disease (CD). Methods Twenty-five CD patients with HMEP comprised the HMEP group, and 25 CD patients without HMEP, who had a similar onset age, sex, and disease course with those in the HMEP group, comprised the non-HMEP group. No underlying liver/biliary disease was observed in any of the patients. Clinical characteristics, laboratory test results, Lemann index, and CD endoscopic index of severity (CDEIS) were compared between the groups using the Student t-, Mann-Whitney U, Chi square, or Fisher's exact tests. Patients received top-down, step-up, or traditional treatment during the follow-up period. After the 1-year follow-up, therapeutic outcomes (active inflammation [CDEIS > 3.5 if the endoscopic data were available, or C-reactive protein level > 5 mg/L if the endoscopic data were unavailable] or remission) were evaluated. Results The occurrence rate of fistulas/abscesses was higher in the HMEP group (84%, 21/25) than in the non-HMEP group (48%, 12/25) with no statistical significance (P = 0.056). The HMEP group showed a higher C-reactive protein level (P = 0.001), erythrocyte sedimentation rate (P = 0.013), and blood platelet count (P = 0.005). There was no significant difference in therapeutic strategies between the groups (P = 0.509). The HMEP group showed a significantly lower remission ratio after anti-inflammatory treatment than the non-HMEP group (P = 0.045). Conclusions HMEP was correlated with increased inflammatory activity and adverse therapeutic outcomes in CD. This finding provided insights regarding novel markers of CD diagnosis and treatment.
机译:None

著录项

  • 来源
    《Abdominal radiology.》 |2021年第7期|共10页
  • 作者单位

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Gastroenterol 58 Zhongshan 2 Rd Guangzhou 510080;

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

    Sun Yat Sen Univ Affiliated Hosp 1 Dept Gastroenterol 58 Zhongshan 2 Rd Guangzhou 510080;

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

    Sun Yat Sen Univ First Affiliated Hosp Dept Radiol 58 Zhongshan 2 Rd Guangzhou 510080 Peoples;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内科学;
  • 关键词

    Crohnamp; 8217; s disease; Mosaic enhancement pattern; Inflammation; Therapy; Disease activity;

    机译:克罗恩&8217;S病;马赛克增强模式;炎症;治疗;疾病活动;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号